Laura has eight years’ experience in academic and clinical research. She held two independent positions as an NHS research fellow in the division of clinical neuroscience, and the department of anaesthesiology from 2011-2013 where she had the opportunity to work closely with consultants and patients on neuroimaging, immunology and endocrinology.
Laura later attained her doctorate in molecular and developmental neuroscience under the supervision of Professor Yves Barde at Cardiff University. During her PhD, Laura used CRISPR and zinc-finger nucleases (ZFNs) to generate genetically modified in vitro and in vivo models that utilised Cre-recombinase to switch genes on and off. She has also worked for five years on the isolation, culture and differentiation of various cell lines, including human and mouse embryonic stem cells (ESCs). She is therefore particularly interested in patents dealing with cell lines, animal models, iPSCs, genome editing, and stem cell technologies.
Laura is a trainee patent attorney at Script IP, working directly with our directors, Dr. Robert Dempster and Dr. John Lloyd. She works on opposition and prosecution cases, patent drafting, and is working towards becoming a UK and EU qualified patent attorney.
Scaling pain threshold with microRNAs. Science (2017), 356 (6343), 1124-1125.
Script IP is a thoroughly professional business, who I would have no hesitation in recommending (except to our competitors).
Matt Quartley, Managing Director, Valeport Ltd